Search
Saturday 16 May 2015
  • :
  • :
Latest Update

4 Sizzling Movers: General Electric Company, (NYSE:GE), T-Mobile US, (NYSE:TMUS), The Western Union Company, (NYSE:WU), Johnson & Johnson, (NYSE:JNJ)

On Tuesday, Shares of General Electric Company (NYSE:GE), gained 0.41% to $27.03, as European Union antitrust regulators resume their investigation into the company’s $13.97 billion plan to buy most of Alstom’s (ALSMY) energy business, according to Reuters.

In late April, Regulators stopped the clock on their review until they received the additional information that was requested, Bloomberg reports.

The European Commission will decide by Aug. 21 whether to clear General Electric’s biggest acquisition, Reuters reports.

General Electric Company (GE) operates as an infrastructure and financial services company worldwide. The company’s Power and Water segment offers gas, steam and aeroderivative turbines, nuclear reactors, generators, combined cycle systems, controls, and related services; wind turbines; and water treatment services and equipment.

Shares of T-Mobile US, Inc. (NYSE:TMUS), inclined 1.74% to $34.56, during its last trading session.

Braxton Carter, Chief Financial Officer, and Neville Ray, Chief Technology Officer of T-Mobile US, will speak at 10:00 a.m. Eastern Daylight Time on Thursday, May 14th at the 2nd Annual Moffett Nathanson Media & Communications Summit in New York, NY.

T-Mobile US, Inc., together with its auxiliaries, provides mobile communications services in the United States, Puerto Rico, and the U.S. Virgin Islands. The company offers voice, messaging, and data services in the postpaid, prepaid, and wholesale markets.

At the end of Tuesday’s trade, Shares of The Western Union Company (NYSE:WU), lost -0.05% to $21.75.

The Western Union Company, declared it has signed a 3 year renewal agreement with Hong Leong Bank Berhad (HLBB) to extend its offering of money transfer services throughout its 283 bank locations in Malaysia.

Since the passing of the Money Services Business Act in 2011 that defined stipulations for the licensing, regulation and supervision of the money changing, remittances and wholesale currency business, there has been a tremendous enhance in outward and inward remittances, with a 3-year compounded annual growth rate of 30% and 20% respectively. This growth is due mainly from senders converting from informal to formal channels for money transfer driven by greater public awareness on the value of using legal channels for remittances plus additional and easier money transfer options through mobile and internet remittance services.

The Western Union Company provides money movement and payment services worldwide. The company operates in three segments: Consumer-to-Consumer, Consumer-to-Business, and Business Solutions. The Consumer-to-Consumer segment offers cash money transfer services involving walk-in agent locations.

Finally, Johnson & Johnson (NYSE:JNJ), ended its last trade with -0.55% loss, and closed at $100.47.

Johnson & Johnson, declared receipt of a further action from the United States Patent and Trademark Office (PTO) regarding the reexamination of U.S. Patent No. 6,284,471 (‘471) regarding REMICADE® (infliximab) in which the PTO maintained its rejection of the patent. Based on the receipt of today’s action, the company’s partner, Janssen Biotech, Inc., will have until June 12 to file a notice of appeal to the PTO’s Patent Trial and Appeal Board and plans to do so.

Presently the ‘471 patent expires in September 2018. Patent ‘471 remains a valid and enforceable patent as it undergoes reexamination at the PTO. Janssen Biotech will continue to defend its intellectual property rights, and if necessary, will pursue all accessible appeals.

Johnson & Johnson, together with its auxiliaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *